Search Results 841-850 of 8076 for TNF
This is a randomized, multicenter, double-blind, placebo-controlled, Phase 2-3 study of patients diagnosed with advanced unresectable dedifferentiated ...
Monoclonal antibodies, such as varlilumab and nivolumab, may work by stimulating the immune system to attack cancer tumor cells. Participation eligibility.
About this study. The purpose of this dose-escalation study is to evaluate the safety, tolerability, pharmacokinetics (PK) and effectiveness of venetoclax, ...
The purpose of this study is to examine the differences in percent of goal calories provided through blenderized tube feeding (BTF) and standard enteral formula ...
About this study. This is an open-label, dose-escalation study of the proviral integration site of Moloney murine leukemia virus (PIM) kinase inhibitor ...
Dr. Gregory Poland 00:04. It's really heartbreaking to watch what's happening with kids. When you look at last week's cases, over a quarter of those are now ...
Clinical Trials · A Study to Evaluate Long Term Change in Tau Deposits by Comparing New Scans with 18F-AV-1451 Uptake, to Scans from Previous Study 18F-AV-1451- ...
Received CD20 inhibitor, anti-tumor necrosis factor treatment, abatacept, alemtuzumab, any other experimental or biological therapy, intravenous ...
The goals of the study are to develop protocols for growing cells isolated from the nasal epithelium and fat tissue. This will be used to help grow nerve- ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.